| Application no. and date | 13779378.2 (espacenet) (Federated) (European Patent Register), 20130815 | | Patent/reg. no. and date | DK/EP 2885266, 20200318 | | Publication date | 20150624 | | Priority no. and date | EP 12180920, 20120817 | | EP pub. no. and date |
EP 2885266 20150624 | | Effective date | | | Applicant/owner | Actelion Pharmaceuticals Ltd, Gewerbestrasse 16
4123 Allschwil, CH | | Applicant ref. no. | 1553464 | | Inventor | HERSE, Christelle, c/o Lonza Ltd
Rottenstrasse 6
CH-3930 Visp, CH | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07C 45/64 (2006.01) , C07C 45/81 (2006.01) , C07C 47/575 (2006.01) , C07D 277/54 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF (2Z,5Z)-5-(3-CHLOR-4-((R)-2,3-DIHYDROXYPROPOXY)BENZYLIDEN)-2-(PROPYLIMINO)-3-(O-TOLYL)THIAZOLIDIN-4-ON OG MELLEMPRODUKT, DER ANVENDES I FREMGANGSMÅDEN | | Int. application no. | IB2013056662 | | Int. publication no. | WO2014027330 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
